Fig. 5

The staining area of cardiac erythrocytes (a) and the thrombotic inhibition percentage (b) of control group, PHZ (1.5 μM), G1 (ASP, 25 μg/mL), G17–G25 (25 μg/mL of DSS, PRAC, PRAL, MA, LA, SAB, SAA, GRg1 and GRb1, respectively). Data are expressed as mean ± SD (n = 3), ^###P < 0.001 versus the control group, *P < 0.05, **P < 0.01 and ***P < 0.001 versus the PHZ-induced model group